The AI tools you use every day — Claude, ChatGPT, Gemini — are, in a meaningful sense, frozen in time. They learned everything they know during a multi-month training run, and then the learning stopped. New research published in 2025 and 2026 is attacking this problem from five different angles simultaneously. Here’s what’s actually working,…
SciPy 1.0 was published in February 2020. In the twelve months ending October 2025 it was cited 1,731 times. That is a five-year-old methods paper picking up roughly five new citations per day, with the rate still climbing. Its acceleration over the prior year is +94 per month, the third highest in the entire top-300…
Most “trending papers” lists are annual cuts: how many times a paper got cited this year versus last. That misses the shape of the curve. A paper that quietly clocked 200 citations evenly across twelve months looks identical to one that went from 5 per month to 40 per month. The second is actually taking…
In 2023 the European Society of Cardiology published its first comprehensive guideline on cardiomyopathies. OpenAlex has already logged more than 2,100 citations to that single document, a pace that puts it among the fastest-accelerating clinical papers of 2024. The guideline itself is not the story. The story is what it quietly codified: a drug class…
Steven Pinker’s Enlightenment Now proves that, on a 200-year baseline, almost everything is up and to the right. Peter Thiel’s The End of the Future argues that, since 1973, almost nothing in the physical world is. Both can be true. The trick is to plot each metric on its own longest available baseline and see…
Peter Thiel said in 2011 that the future had stalled. Ray Kurzweil said in 2005 that the future was on schedule. Reading both texts now, with a 9.3-million-patent corpus running underneath them, the answer is that they were arguing about different decades — and that the inflection between those decades happened, with disconcerting precision, the…
What started as a search for hidden innovation in medical devices turned into something bigger — a vision for how AI-driven R&D will need to coordinate across fields, and the infrastructure that doesn’t exist yet.
The 60-gigahertz radar chip built to stop your car is now being pointed at sleeping chests, and a hot-car safety rule is paying to make it cheap enough for cribs, nightstands, and hospital beds.
Kurzweil predicted three bridges to radical life extension by the 2030s. The first one got demoted, the second arrived in eighteen patients’ eyes, and the third does not exist.
For 80 years the carbon-fluorine bond was unbreakable. Then the EPA set a 4-ppt limit, and the patent office filled up with reactors that mineralize forever chemicals instead of relocating them.
Kurzweil predicted animal aging research would translate to human therapies by the 2020s. The worms did exactly what he said. The translation hit the FDA wall.
From 2022 to 2025, US ammonia engine and turbine patents nearly tripled. The new fuel for marine shipping and gas-turbine power is a chemical the fertilizer industry has been moving by the supertanker for a century.
Kurzweil said the brain’s design fits in less than Microsoft Word. Twenty-one years later, the genome held the line. Word did not.
The patent record shows a hidden federal bet: instead of opening new mines, the US is engineering rare-earth supply out of coal ash, acid mine drainage, and other industrial waste.
Kurzweil said 7-micron machines would swim through every brain capillary by the late 2020s. The size class works in mice; the mechanism he predicted does not exist; and Kurzweil himself just moved the deadline.
Seven reactor designs, one reaction. The hydrogen industry the petrochemical majors are quietly building doesn’t need water, and its byproduct is tire filler.
Kurzweil predicted FIRKO-style metabolic engineering would slim humans and reverse aging in the 2020s. The mice held up. The mechanism didn’t.